MTOR, mechanistic target of rapamycin kinase, 2475

N. diseases: 960; N. variants: 48
Disease: Erythroblastosis ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0272138
Disease: Erythroblastosis
Erythroblastosis 		0.020 Biomarker disease BEFREE Mechanistic target of rapamycin kinase (MTOR) and erythroblastosis oncogene B (ERBB)3 were identified as high-ranking essential kinase hits in the HNSCC cell lines. 31554698 2019
CUI: C0272138
Disease: Erythroblastosis
Erythroblastosis 		0.020 Biomarker disease BEFREE The inhibitory effects occur at the transcriptional level and seem to involve the phosphatidylinositol 3-kinase/mammalian target of rapamycin/erythroblastosis virus transcription factor 2 pathway. 17332326 2007